319 related articles for article (PubMed ID: 18984740)
1. Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens.
Dai YD; Marrero IG; Gros P; Zaghouani H; Wicker LS; Sercarz EE
Diabetes; 2009 Jan; 58(1):156-64. PubMed ID: 18984740
[TBL] [Abstract][Full Text] [Related]
2. Slc11a1, formerly Nramp1, is expressed in dendritic cells and influences major histocompatibility complex class II expression and antigen-presenting cell function.
Stober CB; Brode S; White JK; Popoff JF; Blackwell JM
Infect Immun; 2007 Oct; 75(10):5059-67. PubMed ID: 17620357
[TBL] [Abstract][Full Text] [Related]
3. A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes.
Ferris ST; Carrero JA; Mohan JF; Calderon B; Murphy KM; Unanue ER
Immunity; 2014 Oct; 41(4):657-69. PubMed ID: 25367577
[TBL] [Abstract][Full Text] [Related]
4. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.
Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM
J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727
[TBL] [Abstract][Full Text] [Related]
5. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
6. Rotavirus acceleration of murine type 1 diabetes is associated with increased MHC class I-restricted antigen presentation by B cells and elevated proinflammatory cytokine expression by T cells.
Pane JA; Webster NL; Zufferey C; Coulson BS
Virus Res; 2014 Jan; 179():73-84. PubMed ID: 24246305
[TBL] [Abstract][Full Text] [Related]
7. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J
J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066
[TBL] [Abstract][Full Text] [Related]
8. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.
Stephens LA; Kay TW
Int Immunol; 1995 Dec; 7(12):1885-95. PubMed ID: 8746558
[TBL] [Abstract][Full Text] [Related]
10. Antigen presentation events during the initiation of autoimmune diabetes in the NOD mouse.
Ferris ST; Carrero JA; Unanue ER
J Autoimmun; 2016 Jul; 71():19-25. PubMed ID: 27021276
[TBL] [Abstract][Full Text] [Related]
11. T-cell tolerance by dendritic cells and macrophages as a mechanism for the major histocompatibility complex-linked resistance to autoimmune diabetes.
Thiessen S; Serra P; Amrani A; Verdaguer J; Santamaria P
Diabetes; 2002 Feb; 51(2):325-38. PubMed ID: 11812739
[TBL] [Abstract][Full Text] [Related]
12. IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic Islets.
Falcone M; Yeung B; Tucker L; Rodriguez E; Krahl T; Sarvetnick N
Clin Immunol; 2001 Feb; 98(2):190-9. PubMed ID: 11161975
[TBL] [Abstract][Full Text] [Related]
13. Resident macrophages of pancreatic islets have a seminal role in the initiation of autoimmune diabetes of NOD mice.
Carrero JA; McCarthy DP; Ferris ST; Wan X; Hu H; Zinselmeyer BH; Vomund AN; Unanue ER
Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10418-E10427. PubMed ID: 29133420
[TBL] [Abstract][Full Text] [Related]
14. The neonatal FcR-mediated presentation of immune-complexed antigen is associated with endosomal and phagosomal pH and antigen stability in macrophages and dendritic cells.
Liu X; Lu L; Yang Z; Palaniyandi S; Zeng R; Gao LY; Mosser DM; Roopenian DC; Zhu X
J Immunol; 2011 Apr; 186(8):4674-86. PubMed ID: 21402891
[TBL] [Abstract][Full Text] [Related]
15. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
16. Processing and presentation of the islet autoantigen GAD by vascular endothelial cells promotes transmigration of autoreactive T-cells.
Greening JE; Tree TI; Kotowicz KT; van Halteren AG; Roep BO; Klein NJ; Peakman M
Diabetes; 2003 Mar; 52(3):717-25. PubMed ID: 12606513
[TBL] [Abstract][Full Text] [Related]
17. Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens.
Green EA; Eynon EE; Flavell RA
Immunity; 1998 Nov; 9(5):733-43. PubMed ID: 9846494
[TBL] [Abstract][Full Text] [Related]
18. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes.
Höglund P; Mintern J; Waltzinger C; Heath W; Benoist C; Mathis D
J Exp Med; 1999 Jan; 189(2):331-9. PubMed ID: 9892615
[TBL] [Abstract][Full Text] [Related]
19. Adoptive transfer of islet antigen-autoreactive T cell clones to transgenic NOD.Ea(d)mice induces diabetes indicating a lack of I-E mediated protection against activated effector T cells.
Roberts SA; Barbour G; Matarrese MR; Mason DL; Leiter EH; Haskins K; Hanson MS
J Autoimmun; 2003 Sep; 21(2):139-47. PubMed ID: 12935783
[TBL] [Abstract][Full Text] [Related]
20. The central role of antigen presentation in islets of Langerhans in autoimmune diabetes.
Calderon B; Carrero JA; Unanue ER
Curr Opin Immunol; 2014 Feb; 26():32-40. PubMed ID: 24556398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
